Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer
- PMID: 22291073
- PMCID: PMC3295567
- DOI: 10.1200/JCO.2011.36.7508
Comparative effectiveness of robotic versus laparoscopic hysterectomy for endometrial cancer
Abstract
Purpose: Use of robotics in oncologic surgery is increasing; however, reports of safety and efficacy are from highly experienced surgeons and centers. We performed a population-based analysis to compare laparoscopic hysterectomy and robotic hysterectomy for endometrial cancer.
Patients and methods: The Perspective database was used to identify women who underwent a minimally invasive hysterectomy for endometrial cancer from 2008 to 2010. Morbidity, mortality, and cost were evaluated using multivariable logistic and linear regression models.
Results: We identified 2,464 women, including 1,027 (41.7%) who underwent laparoscopic hysterectomy and 1,437 (58.3%) who underwent robotic hysterectomy. Women treated at larger hospitals, nonteaching hospitals, and centers outside of the northeast were more likely to undergo a robotic hysterectomy procedure, whereas black women, those without insurance, and women in rural areas were less likely to undergo a robotic hysterectomy procedure (P < .05 for all). The overall complication rate was 9.8% for laparoscopic hysterectomy versus 8.1% for robotic hysterectomy (P = .13). The adjusted odds ratio (OR) for any morbidity for robotic hysterectomy was 0.76 (95% CI, 0.56 to 1.03). After adjusting for patient, surgeon, and hospital characteristics, there were no significant differences in the rates of intraoperative complications (OR, 0.68; 95% CI, 0.42 to 1.08), surgical site complications (OR, 1.49; 95% CI, 0.81 to 2.73), medical complications (OR, 0.64; 95% CI, 0.40 to 1.01), or prolonged hospitalization (OR, 0.85; 95% CI, 0.64 to 1.14) between the procedures. The mean cost for robotic hysterectomy was $10,618 versus $8,996 for laparoscopic hysterectomy (P < .001). In a multivariable model, robotic hysterectomy was significantly more costly ($1,291; 95% CI, $985 to $1,597).
Conclusion: Despite claims of decreased complications with robotic hysterectomy, we found similar morbidity but increased cost compared with laparoscopic hysterectomy. Comparative long-term efficacy data are needed to justify its widespread use.
Conflict of interest statement
Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.
Figures
Comment in
-
Potential pitfalls of the rapid uptake of new technology in surgery: can comparative effectiveness research help?J Clin Oncol. 2012 Mar 10;30(8):767-9. doi: 10.1200/JCO.2011.39.4247. Epub 2012 Jan 30. J Clin Oncol. 2012. PMID: 22291075 No abstract available.
-
Adoption of robotic surgery: an analogy from urologic oncology.J Clin Oncol. 2012 Aug 10;30(23):2931-2; author reply 2932-3. doi: 10.1200/JCO.2012.42.4895. Epub 2012 Jul 2. J Clin Oncol. 2012. PMID: 22753920 No abstract available.
References
-
- Wilson EB. The evolution of robotic general surgery. Scand J Surg. 2009;98:125–129. - PubMed
-
- Barnett JC, Judd JP, Wu JM, et al. Cost comparison among robotic, laparoscopic, and open hysterectomy for endometrial cancer. Obstet Gynecol. 2010;116:685–693. - PubMed
-
- Veljovich DS, Paley PJ, Drescher CW, et al. Robotic surgery in gynecologic oncology: Program initiation and outcomes after the first year with comparison with laparotomy for endometrial cancer staging. Am J Obstet Gynecol. 2008;198:679.e1–9. - PubMed
-
- Boggess JF, Gehrig PA, Cantrell L, et al. A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: Robotic assistance, laparoscopy, laparotomy. Am J Obstet Gynecol. 2008;199:360.e1–9. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
